Cybercriminals’ tactics have evolved to target sensitive data and disrupt research and development in the pharmaceutical ...

The pharmaceutical industry is undergoing a profound transformation, driven by the increasing complexity of drug development and the need for greater efficiency and cost-effectiveness. At the ...

Having an independent review of all of your manufacturing sites from an independent third party can be an excellent way to identify key risks and start any necessary remediation plans.

An analysis by ING Bank suggests that proposed tariffs could increase the cost of certain cancer treatments by up to $10,000 ...

The biopharmaceutical industry loses approximately $35 billion annually due to temperature-control failures within the supply chain, which often results in products being damaged or destroyed.

The pharmaceutical industry is undergoing a paradigm shift, driven by cutting-edge technologies and new digital capabilities. This transformation, known as Pharma 4.0, is akin to the fourth industrial ...

CDMOs are flexible third-party service providers that are entrusted with all the stages of the process of making medicines. (Reuters) Here’s an acronym that you probably hear almost everyday on ...